Kiora Pharmaceuticals (KPRX) Leases (2019 - 2025)
Kiora Pharmaceuticals (KPRX) has disclosed Leases for 7 consecutive years, with $318036.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Leases rose 337.84% year-over-year to $318036.0, compared with a TTM value of $318036.0 through Sep 2025, up 337.84%, and an annual FY2024 reading of $57170.0, down 46.52% over the prior year.
- Leases was $318036.0 for Q3 2025 at Kiora Pharmaceuticals, down from $349017.0 in the prior quarter.
- Across five years, Leases topped out at $349017.0 in Q2 2025 and bottomed at $18725.0 in Q3 2023.
- Average Leases over 5 years is $160349.0, with a median of $149769.5 recorded in 2022.
- The sharpest move saw Leases crashed 87.3% in 2023, then soared 337.84% in 2025.
- Year by year, Leases stood at $209411.0 in 2021, then dropped by 29.59% to $147456.0 in 2022, then decreased by 27.51% to $106890.0 in 2023, then plummeted by 46.52% to $57170.0 in 2024, then skyrocketed by 456.3% to $318036.0 in 2025.
- Business Quant data shows Leases for KPRX at $318036.0 in Q3 2025, $349017.0 in Q2 2025, and $152083.0 in Q1 2025.